Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology

By sjmartinez • August 2, 2024

Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, Ciardiello F, Pane F, Au L, Emmerich M, Plummer C, Gulati G, Ramalingam S, Cardinale D, Brezden-Masley C, Iakobishvili Z, Thavendiranathan P, Santoro C, Bergler-Klein J, Keramida K, de Boer RA, Maack C, Lutgens E, Rassaf T, Fradley MG, Moslehi J, Yang EH, De Keulenaer G, Ameri P, Bax J, Neilan TG, Herrmann J, Mbakwem AC, Mirabel M, Skouri H, Hirsch E, Cohen-Solal A, Sverdlov AL, van der Meer P, Asteggiano R, Barac A, Ky B, Lenihan D, Dent S, Seferovic P, Coats AJS, Metra M, Rosano G, Suter T, Lopez-Fernandez T, Lyon AR. Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail. 2024 Aug 1. doi: 10.1002/ejhf.3340. Epub ahead of print. PMID: 39087551.

Tags: cardio‐oncology, Cardiology/Epi, cardiotoxicity, Hematology/Oncology, Immunotherapies, Publications

Cross-pollination of two specialties: potential repurposing of cancer and cardiovascular drugs for the benefit of the other

Leiva O, DeCara JM, Yang EH, Gozdecki L, Kanelidis A, Swat S. Cross-pollination of two specialties: potential repurposing of cancer and cardiovascular drugs for the[...]

Primary Central Nervous System (CNS) Post-Transplant Lymphoproliferative Disorder: A Case Report

Taitt JM, Lees C, Tran GN, Patel S. Primary Central Nervous System (CNS) Post-Transplant Lymphoproliferative Disorder: A Case Report. Cureus. 2025 Oct 21;17(10):e95108. doi: 10.7759/cureus.95108.[...]

Trends and disparities in mortality associated with peripheral artery disease and hyperlipidemia, 1999-2024

Khan S, Hassan M, Hussain M, Dhedhi HAA, Fatima W, Nawaz J, Ahsan A, Pirih FNU, Khalid N, Qaisar M, Qureshi AA, Baig M, Eltawansy[...]